Prior authorization, the coverage checkpoint that decides whether a treatment gets paid for, has turned into one of the sharpest battlegrounds in American medicine, and Otter Health is entering it with $8 million in new funding. The bet is that the request itself, not the appeal that follows a denial, is where clinical time gets saved.
That framing sets the company apart from a wave of tools built simply to generate appeals faster. Rather than handing one side of the dispute a better argument, Otter aims to settle coverage questions early, before they harden into denials that pull clinicians away from patients and paperwork away from care.
The problem is large. Prior authorization eats significant clinician and administrative hours, and both insurers and health systems have fielded automated systems against one another. That escalation has drawn scrutiny from regulators and lawmakers worried about denials produced without any human review at all.
Relative to other digital health raises, the sum is modest, but it lands in a category where even small workflow improvements return real hours to clinical staff. Otter joins a crowded field of well-funded startups selling AI that drafts authorization letters, forecasts denial risk or negotiates claims on a provider’s behalf.
